Dominic Williams

I currently lead the AZ preclinical hepatic safety strategy & sit on the Translational Safety Leadership team. I am the co-ordinator of the IMI JU consortia ‘MIP-DILI’. Prior to joining AstraZeneca, I had 12 years of academic experience in translational hepatic drug safety from within the UKs only MRC funded Centre for Drug Safety Science. I have authored over 70 peer-reviewed publications on drug safety, and brought in academic funding of over £10M.